 Metformin ameliorates sevoflurane-induced neurocognitive impairment in aged mice through activation of autophagy.
Introduction
Neurocognitive impairment is increasingly recognized as a significant complication after surgery and anaesthesia, particularly among older adults (Moller et al., 1998; Newman et al., 2001) . Laboratory evidence suggests that general anaesthetics may be neurotoxic to the extremes of age (Bittner et al., 2011; Culley et al., 2004; Deng et al., 2014; Raper et al., 2015) . Several reports find a strong association between ageing and downregulation or deregulation of autophagic activity (Cuervo, 2008; Xu et al., 2016) . The activation of autophagy reversed the ageing process of important organs such as the heart (Zhang et al., 2017) and brain (Loos et al., 2017) . Moreover, ample evidence suggests that a basal level of autophagic activity is required for lifespan extension and memory improvement (Loeffler, 2019; Ren et al., 2017) , and an accrual J o u r n a l P r e -p r o o f of defects in autophagy may be a crucial driver of neurodegeneration, ultimately leading to neurocognitive impairment (Liang and Sigrist, 2018b; Son et al., 2012) . However, little is known about the effects of anaesthesia on autophagy dysfunction causally related to cognitive deficiency and the possible underlying mechanism.
Autophagy is an intracellular catabolic system that degrades misfolded proteins and damaged organelles to maintain essential cellular activity and viability (Mizushima et al., 2008) . Specifically, in the central neural system, autophagy plays a pivotal role in neuronal homeostasis (Harris and Rubinsztein, 2012; Nixon, 2013) . Accumulating evidence suggests that autophagy is involved in anaesthetic neurotoxicity. An in vitro study showed that propofol-mediated neural progenitor cell survival and neurogenesis are closely associated with the effects of propofol on autophagy (Qiao et al., 2017) .
Moreover, anaesthesia with 1.5% isoflurane for 4 h influences autophagy in the hippocampus as reflected by decreased levels of light chain II (LCII) and Beclin 1 and increased levels of P62 in aged rats (Li et al., 2015) . At present, the impact of sevoflurane (Sev) anaesthesia on autophagic activity in the ageing brain is largely unknown.
Metformin (Met), a commonly used antihyperglycaemic drug, rapidly crosses the blood-brain barrier once in circulation and accumulates in several brain regions, such as the pituitary gland, olfactory bulb and hippocampus (Labuzek et al., 2010) . Recent clinical studies have confirmed that long-term use of Met reduces the risk of cognitive decline in patients with Alzheimer's disease, Huntington's disease and Type 2 diabetes mellitus (T2DM) (Markowicz-Piasecka et al., 2017) . However, the potential mechanisms underlying these benefits in improving cognition are complex and still not fully described. Interestingly, Met has been shown to directly activate neuronal AMPactivated protein kinase (AMPK) at Thr172 in the hippocampus in various models of disease, such as Alzheimer's disease (Ou et al., 2018) and cerebral ischaemia (Jiang et al., 2014) . AMPK acts as a sensor of cellular energy status, and its activation can induce macroautophagy by phosphorylating the serine/threonine kinase ULK1 (Kim et al., 2011; Russell et al., 2013) .
J o u r n a l P r e -p r o o f
However, whether Met has the capacity to attenuate anaesthesia-induced neurocognitive impairment via regulating autophagy has not been investigated, and the AMPK-ULK1-dependent autophagic pathway involved in Met-mediated neuroprotection has not been defined. Accordingly, we hypothesized that Met might mitigate neurocognitive impairment in aged mice induced by Sev anaesthesia through AMPK-ULK1-dependent autophagy. Here, data from our present study provide strong evidence that neuronal autophagy is reduced in the hippocampus of 20-month-old mice following Sev anaesthesia and that activation of autophagy by Met corrects Sevinduced synaptic abnormalities and cognitive impairment through an AMPK-ULK1 interaction.
Materials and Methods

Animals
Male 20-month-old C57BL/6 mice weighing 25-35 g were purchased from Changzhou Cavens Laboratory Animal Co., Ltd. (Jiangsu, China). Animals were housed under a 12-h light-dark cycle at a constant temperature of 20-24 °C and a humidity of approximately 30% with free access to water and food. All animal procedures were approved by the Animal Ethics Committee of Zhongnan Hospital of Wuhan University, and all experiments were carried out in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals (Bethesda, Maryland, USA). Every effort was made to minimize the number of animals and their suffering.
Mouse anaesthesia and treatment
Sevoflurane (Sev, CAS number: 84251) was obtained from Maruishi Chemical Pharmaceutical Co., Ltd., Japan. Metformin hydrochloride (Met, CAS number: 1115-70-4) . Compound C (Cpd, CAS number: 866405-64-3) and 3-methyladenine (3-MA, CAS number: 5142-23-4) were purchased from Sigma-Aldrich Inc., St. Louis, MO, USA. Randomization methods were used to assign animal groups. To explore the neuroprotective effects of Met on old mice after Sev anaesthesia, mice were pretreated J o u r n a l P r e -p r o o f with 200 mg/kg Met via oral gavage once daily for 14 days (Sarkaki et al., 2015 ) . Next, to determine whether autophagy is involved in Met-mediated neuroprotection, we administered 30 mg/kg 3-MA (Wang et al., 2019) once daily for 14 days via intraperitoneal injections for 60 minutes before each of the metformin pretreatments.
Finally, to investigate the molecular mechanism of Met-mediated neuroprotection, 20 mg/kg Cpd (Ou et al., 2018) were administered to mice once daily for 14 days through intraperitoneal injections for 60 minutes before each of the metformin pretreatments.
The mice in the control condition received normal saline once daily for 14 days. At day 14, mice were exposed to 3% Sev plus 60% oxygen (balanced with nitrogen) at 30 min after drug treatment of the drugs for 2 h at a flow rate of 2 L/min. Mice in the control condition were exposed to 60% oxygen at an identical flow rate. The size of the anaesthesia chamber was 22 ×12×15 cm. Both sides of the chamber were connected to a Fabius anaesthesia machine (Draeger Company, Germany) and gas monitor (Draeger Company, Germany). The temperature of the chamber was maintained at 37 °C by a heat plate. We continually monitored the Sev concentration and partial pressure of endtidal carbon dioxide (ETCO2) using the gas monitor. The saturated oxygen in arterial blood (SpO2) was measured using a pulse oximeter for animals (Kent, USA). There was no difference in the values of ETCO2 or SpO2 among the various groups.
2.3.Morris water maze
Twenty-four hours after Sev exposure (at day 15), mice were subjected to the Morris water maze test to detect spatial learning and memory from day 15 to day 20.
Referencing the method of Vorhees and Williams (Vorhees and Williams, 2006) , we performed the test for a total of 6 days, including five days of acquisition training and one day for the probe trial. The water maze system consisted of a white circular pool with a diameter of 100 cm and a height of 60 cm. The round pool was filled with water to a depth of 40 cm, and the water temperature was maintained at 22 to 24 °C. The pool was divided into four quadrants: the east, the west, the south and the north. The east quadrant was randomly selected as the target quadrant, and the platform was submerged 1 cm under the surface of the water. A camera was positioned above the pool to track J o u r n a l P r e -p r o o f the movement of mice. Each mouse was trained 4 times per day during acquisition training. The mice were randomly placed into each quadrant facing the pool wall during five consecutive days of training. Each mouse was given 60 s to locate the hidden platform. If the mouse could not find the platform, the researchers guided them to the platform. All mice were allowed to stay on the platform for a 15-s break. The average time to locate platform 4 times was referred to as the escape latency on that day. On the sixth day, the platform was removed, and mice were placed into the water in the opposite quadrant. The test lasted 60 s, and the time spent in the east quadrant was recorded.
2.4.Western blotting
After the Morris water maze test, the mice were immediately killed in a completely anaesthetized condition (at day 20). The hippocampi were harvested for the following experiments. For Western blotting, the proteins were extracted by RIPA lysis buffer (Aspen Biotechnology, China). Different samples of proteins were separated on SDS polyacrylamide gels and subsequently transferred to PVDF membranes. The membranes were incubated overnight at 4 °C with primary antibodies against the following proteins: phosphorylated (P-) AMP-activated protein kinase (AMPK) (Thr172)(1:1000; 2535; Cell Signaling Technology (CST), USA), AMPK (1:1000; 2532; CST), P-ULK1 (Ser317) (1:1000; 12753; CST), P-ULK1 (Ser777) (1:500; ABC213; Millipore Sigma, USA), ULK1 (1:1000; 8054; CST), Beclin 1 (1:1000; 3738; CST), ATG5 (1:1000; 12994S; CST), ATG7 (1:1000; 8558S; CST), light chain 3 (LC3; 1:1000; 2775; CST), P62 (1:800; 5114; CST) and β-actin (1:10000; Aspen). After the membranes were washed with 1 × TBST, they were incubated with HRP-coupled secondary antibodies (Aspen, China) for 1.5 h. Immunoreactivity was detected by a chemiluminescent imaging system (Tanon, China). β-Actin was used as a loading control. The band intensity was measured using ImageJ software (National Institutes of Health, USA).
2.5.Transmission electron microscopy
The hippocampal tissues were fixed with 0.25% glutaraldehyde overnight at 4 °C.
J o u r n a l P r e -p r o o f
After being rinsed with phosphate-buffered saline, the samples were post-fixed with 1% osmium tetroxide for 2 h. The tissues were dehydrated with acetone and embedded in an epoxy resin. Ultrathin sections were cut and stained with 4% lead citrate for 20 min and with 0.5% lead citrate for 5 min. The samples were subjected to transmission electron microscopy (TEM) for observing autophagosomes and synapse density. To calculate autophagosomes, 4 slices were analysed from each hippocampus, and 4 neurons per slice were employed in the analysis. The average number of autophagosomes per neuron were subsequently calculated (Zhang et al., 2016b) . For synaptic density, approximately 10 electron micrographs per animal were analysed. The area of each photograph (area of each micrograph ≈ 15 μm 2 ; Scale bar, 1 μm) was measured, and the areal density of synapses (number of synapses per area, NA) was determined. Finally, the synapse density was expressed as volumetric density (NV = NA/average synaptic length) (Erisir and Harris, 2003) . These measurements were conducted by investigators who were blind to the group assignment of the animals.
Immunofluorescence
The paraffin slides were incubated with 10% goat serum for 1.5 h at room temperature. The slides were then separately incubated with primary antibodies against microtubule-associated protein 2 (MAP2; 1:200, M13; Thermo Fisher, USA), postsynaptic density 95 (PSD95; 1:150, ab2723; Abcam, UK) and LC3 (1:200; 2775; CST). The slides were washed with PBS and incubated with CY3-conjugated antimouse IgG (to label MAP2 and PSD95) and FITC-conjugated anti-rabbit IgG (to label LC3) (all secondary antibodies from Aspen) at room temperature. Nuclei were then counterstained with DAPI (Aspen). An Aperio VERSA 8 microscope (Leica, Germany) was used to acquire images of the hippocampus under 400× magnification. The average intensity of MAP2 and PSD95 and the number of LC3-positive cells (Zhu et al., 2018) were analysed using Image Pro Plus 6.0 software (Media Cybernetics, USA) by observers who were blinded to the experimental groups.
Statistical analysis
Data are expressed as the mean ± S.E. M and were analysed by one-way ANOVA J o u r n a l P r e -p r o o f followed by the post hoc Tukey's test using SPSS 20.0 (SPSS Inc., USA). Since time and treatment act as interaction factors during learning acquisition in the Morris water maze, escape latency was analysed by two-way RM ANOVA followed by Bonferroni test (Jia et al., 2016) . P < 0.05 was considered statistically significant.
Results
Metformin ameliorates sevoflurane-induced neurocognitive impairment through activation of autophagy
Previous studies have demonstrated that exposure of the ageing brain to Sev induces cognitive dysfunction in old rodents (Le Freche et al., 2012; Yan et al., 2019) .
Consistently, the escape latency of elderly mice in the Sev group (Sev group) was longer (Fig. 1C) , and the percent time in the target quadrant was lower ( Fig. 1D ) than those of mice in the control group (Con group), suggesting that Sev anaesthesia induced cognitive impairment in old mice. However, in mice pretreated with Met (Sev+Met group), Sev did not induce cognitive impairment, as indicated by a shorter escape latency (Fig. 1C ) and greater percent time in the target quadrant ( Fig. 1D ) compared to those in Sev-exposed mice. Next, to elucidate the role of autophagy in the Met-mediated improvement of cognitive function, 3-MA was used to selectively block autophagy.
Mice administered 3-MA exhibited cognitive impairment compared to mice in the Sev+Met group, as demonstrated by an increased escape latency (Fig. 1C ) and decreased percent time in the target quadrant ( Fig. 1D) . Western blot analysis of the brain homogenates of these mice further revealed that treatment with 3-MA inhibited autophagy in mice treated with Met and Sev, as shown by a significant reduction in Beclin1 ( Fig. 1E and F) and a significant increase in P62 ( Fig. 1E and G) . Together, these results indicate that Met may ameliorate Sev-induced cognitive impairment in old mice via activation of autophagy. 
Metformin rescues synaptic decline after sevoflurane anaesthesia via the autophagy pathway
Given that Sev anaesthesia induces cognitive impairment in old mice, we investigated whether Sev exposure acts on synaptic integrity in the hippocampus of old mice by measuring the levels of microtubule-associated protein 2 (MAP2), postsynaptic density 95 (PSD95) and synaptic density in the hippocampus. MAP2, a microtubuleassociated proteins, is predominantly located in neuronal dendrites, and its loss may be considered a predictor of impending neuronal death (Posmantur et al., 1996) . PSD95, a postsynaptic marker, is critical for the proper formation and maintenance of excitatory synapses, and a reduction in its expression in the hippocampus directly correlates with cognitive deficits (Wakade et al., 2010) . In the present study, most dendrites in the hippocampus of Sev-exposed mice appeared irregular, shortened and broken compared to those in the Con group with an organized arrangement ( Fig. 2A) . Consistently, we observed significant reductions in MAP2 immunoreactivity ( Fig. 2A ), PSD95 immunoreactivity ( Fig. 2B ) and synaptic density (Fig. 3A and B ) in mice following Sev anaesthesia. However, Met pretreatment corrected Sev-induced aberrant dendrites ( Fig.   2A ) and reversed the Sev-induced reductions in the levels of MAP2 immunoreactivity ( Fig. 2A) , PSD95 immunoreactivity ( Fig. 2B ) and synaptic density (Fig. 3A and B) .
These beneficial effects of Met were significantly blocked by 3-MA, as evidenced by dendrite abnormalities and decreased levels of MAP2 immunoreactivity ( Fig. 2A ), PSD95 immunoreactivity ( Fig. 2B ) and synaptic density (Fig. 3A and B) 
Metformin induces the upregulation of autophagy after sevoflurane anaesthesia
Autophagy is a process that controls the proper development and growth of synapses in developing and ageing brains (Shen et al., 2015; Shen and Ganetzky, 2009 ).
To further confirm that autophagy is involved in Sev-induced synaptic decline, we measured the autophagy-associated proteins Beclin 1, ATG5, ATG7, light chain 3 (LC3) and P62 in the hippocampus. In the present study, Sev anaesthesia significantly reduced autophagic activities in the hippocampus, as demonstrated by reductions in the levels of Beclin 1, ATG5, and ATG7 ( Fig. 4A and B ) and the number of LC3-positive cells ( Fig. 4C) and increases in the levels of P62 ( Fig. 4A and B ). However, compared to Sev treatment alone, treatment with Met increased the levels of Beclin 1, ATG5, and ATG7 ( Fig. 4A and B ) and the number of LC3-positive cells (Fig. 4C ) and decreased the levels of P62 (Fig. 4A and B) . Moreover, the Met-induced upregulation of Beclin 1, ATG5, and ATG7, the increased number of LC3-positive cells and the downregulation of P62 were reversed by 3-MA administration (Fig. 4A, B and C) , further suggesting that Met preconditioning may restore the Sev-induced decrease in autophagy in the hippocampus. 
Metformin promotes autophagy by activating the AMPK-ULK1 pathway
Because the AMPK-ULK1 interaction is well known to positively regulate autophagy induction, we further investigated whether the AMPK-ULK1 interaction is involved in Met-mediated elevations in autophagic activities in Sev-anaesthetized mice.
In this study, pretreatment with Met significantly enhanced the AMPK-ULK1 interaction in the hippocampus of Sev-exposed mice, as indicated by increased phosphorylation of AMPK at Thr172 and phosphorylation of ULK1 at Ser317 and Ser777 ( Fig. 5A and B) . However, treatment with Cpd, a well-established AMPK inhibitor, markedly abrogated the Met-mediated activation of the AMPK-ULK1 interaction, as shown by decreased phosphorylation of AMPK and ULK1 (Fig. 5A and   B ). Inhibiting the AMPK-ULK1 interaction by Cpd effectively abolished Met-induced autophagy induction, as reflected by reductions in Beclin 1, ATG5 and ATG7 expression and the LC3-II/LC3-I ratio and an increase in P62 expression in the hippocampus of mice treated with Sev ( Fig. 5C and D) . Moreover, the Met-induced increase in autophagosomes in hippocampal neurons was also reversed by Cpd administration (Fig. 5E ), suggesting that Met attenuates Sev-induced autophagy inhibition in hippocampal neurons by activation of the AMPK-ULK1 pathway. 
Discussion
In the present study, pretreatment of Met rescued cognitive decline and synapse loss in the hippocampus of the old mice after Sev anaesthesia. Autophagy upregulation has been shown to have a neuroprotective and anti-ageing role (Liang and Sigrist, 2018a; Vijayan and Verstreken, 2017) . These protective effects were largely abolished by 3-MA, which is commonly used to selectively block autophagy. Moreover, the AMPK inhibitor Cpd reversed the effect of Met by reducing activation of AMPK and phosphorylation of ULK1. Taken together, these observations indicate that Met promotes autophagy in aged mice exposed to Sev by activation of the AMPK-ULK1 pathway, suggesting that Met could be used to prevent or treat anaesthesiainduced cognitive deficiency in old mice.
Numerous elderly patients experience memory loss and difficulties with attention and fine motor coordination after surgery and anaesthesia. The aged brain suffers from reduced rates of neurogenesis and synaptogenesis and accumulation of potentially toxic byproducts, and exposure to anaesthesia after age 65 has been linked to long-term changes in brain function (Bittner et al., 2011) . In recent years, emerging evidence has suggested that the inhalation of anaesthetics may contribute to the onset and progression of neurocognitive impairment (Monk and Price, 2011) . In this study, 20-month-old mice, equivalent to 65-year-old humans (Dutta and Sengupta, 2016), were exposed to 3% Sev, a commonly used inhaled anaesthetic, for 2 h. Our findings are generally in agreement with earlier reports showing that exposure of aged mice to Sev impairs spatial learning and memory (Guo et al., 2018; Le Freche et al., 2012) . Cognitive capacity is contingent upon the integrity of synapses, and synapse perturbations are translated to neurobehavioural abnormalities. Inhalational anaesthetics reportedly interfere with synaptic integrity in the developing brain (Vutskits, 2012) and ageing brain (Kong et al., 2013) . However, little is known about how to reverse these anaesthetic-induced synaptic deficits. Our findings herein address whether Met can rescue synaptic-associated pathologies after Sev exposure. We showed that Sev anaesthesia reduced MAP2 and PSD95 expression and the synaptic density, all of which were preserved by preconditioning with Met, suggesting that Met prevents cognitive dysfunction in old mice after anaesthesia by maintaining synaptic integrity.
An earlier study showed that Met administration reversed cisplatin-induced structural abnormalities in dendritic spines and neuronal arborizations in the adult mouse brain (Zhou et al., 2016) . The authors speculated that increased mitochondrial health in cerebral synaptosomes may be the mechanism contributing to the beneficial effects of Met. Wang et al. additionally documented that Met was able to promote neurogenesis and synaptogenesis in the adult mouse brain through the activation of the atypical protein kinase C-CREB-binding protein (PKC-CBP) pathway (Wang et al., 2012) . However, little is known about the mechanisms underlying the regulatory function of Met in synaptic dysfunction in the ageing mouse brain after anaesthesia. It is well known that autophagy is essential for maintaining the integrity of synaptic structure and function, and upregulation of autophagy has been considered a means to combat synaptic dysfunction as well as cognitive defects in neurodegenerative diseases (Vijayan and Verstreken, 2017) . Autophagy activation has been identified as a requirement during synaptogenesis, as autophagosomes are distributed in the synaptic terminals of the hippocampal neurons (Petralia et al., 2013; Shen et al., 2015) . The link between inhaled anaesthetics and neurodegenerative changes is dose-and contextspecific (Bittner et al., 2011) . We therefore aimed to investigate the effects of autophagy on synaptic alterations in the ageing brain following anaesthesia. In the present study, autophagic activity declined after Sev exposure. Deficient autophagy may have J o u r n a l P r e -p r o o f contributed to the reductions in the levels of MAP2 and PSD95 and the synaptic density, as activation of autophagy by Met normalized the synaptic decline. Furthermore, the integrity of the synapse was not restored when autophagy induction was inhibited by 3-MA. Similarly, a previous study showed that a single dose of Met (10 mg/kg) in a rat model of global cerebral ischaemia significantly reduced infarct volume, neurological deficits and neural cell apoptosis by activating autophagy in the hippocampus (Jiang et al., 2014) . Thus, our results, consistent with these observational data, indicate that Met may protect against anaesthesia-induced synaptic dysfunction in the ageing mouse brain through an autophagy-dependent mechanism.
AMPK, the central regulator of cellular energy homeostasis, plays critical roles in regulating autophagy (Mihaylova and Shaw, 2011) . AMPK can be phosphorylated and activated in response to an increase in the intracellular AMP/ATP or ADP/ATP ratio (Hardie, 2003) . The inhibition of mitochondrial respiratory-chain complex 1, which leads to an increase in both the ADP/ATP and AMP/ATP ratios, can explain the ability of Met to activate AMPK (Foretz et al., 2014; Hawley et al., 2010) . It has also been proposed that AMPK can be activated by low concentrations of Met through the AXIN/LKB1-v-ATPase-Ragulator pathway independently of an increase in the AMP/ATP ratio (Zhang et al., 2016a) . In neurons, AMPK is strategically positioned at the soma and synaptic sites where it can promote entire or local neuronal autophagy (Turnley et al., 1999) . Emerging evidence suggests that Met can promote autophagy through an AMPK-dependent manner in the hippocampus (Jiang et al., 2014; Zhu et al., 2018) , but the downstream AMPK pathway by which Met activates autophagy in the brain needs to be determined. Recent evidence demonstrated that once AMPK is activated, AMPK phosphorylates and activates ULK1 at Ser317 and Ser777 (Kim et al., 2011) . The activation of ULK1, in turn, promotes phosphorylation of Beclin 1 at Ser14, an essential step in autophagy initiation (Russell et al., 2013) . Beclin 1 promotes the lipidation of microtubule-associated protein 1 light chain 3 (LC3-I) to produce the autophagosome-associated form LC3-II during the process of elongation. ATG7 is required for the conjugation of ATG12 to ATG5 and activates LC3-I, which is directly associated with autophagosome formation. Finally, autophagosomes are linked by adaptor proteins such as P62 to deliver aggregated proteins to lysosomes for degradation (Rubinsztein et al., 2012) . In the present study, Met activated AMPK by phosphorylating Thr172, which then phosphorylated ULK1 at Ser317 and Ser777, increased Beclin 1, ATG5 and ATG7 levels, the LC3-II/LC3-I ratio and autophagosome accumulation, and reduced P62 levels in Sev-exposed mice, indicating the activation of autophagy. In addition, the activation of the AMPK-ULK1 pathway and the resulting enhanced autophagic activity were inhibited by Cpd treatment, further confirming that Met promotes autophagy by activating the AMPK-ULK1 pathway in ageing brains following anaesthesia.
Conclusions
In conclusion, these results imply that anaesthesia at a clinically relevant concentration causes a reduction in autophagy activity, which induces synaptic dysfunction, finally leading to cognitive deficiency in aged mice. Furthermore, Met rescues the Sev-induced synaptic decline and neurocognitive impairment via an AMPK-ULK1 interaction. More importantly, our results provide clues for targeted interventions for potential cognitive dysfunction after anaesthesia and surgery in elderly patients.
